Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

PathoGenesis seeks Canadian approval for TOBI in CF

March 25, 1998

New antiasthmatic agents claimed by Byk Gulden

March 25, 1998

Epi-2010, a novel antisense oligonucleotide for asthma

March 24, 1998

Jak-2 inhibitor indicated for control of allergic inflammation

March 24, 1998

Clinical efficacy demonstrated for rhuMAb-E25 in asthma

March 24, 1998

PPL's AAT granted orphan drug status by FDA

March 24, 1998

Preliminary clinical efficacy demonstrated for PDE III inhibitor in asthma

March 24, 1998

Phase III trial of Procysteine i.v. suspended

March 23, 1998

Mochida describes new antiasthma agent with novel profile

March 23, 1998

L-0066: a novel inhibitor of PDE IV and mediator release in vitro

March 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...